Publication related to RSI or an RSI staff member

Probabilistic Multiple-Bias Modeling Applied to the Canadian Data From the Interphone Study of Mobile Phone Use and Risk of Glioma, Meningioma, Acoustic Neuroma, and Parotid Gland Tumors.

We undertook a re-analysis of the Canadian data from the 13-country case-control Interphone Study (2001-2004), in which researchers evaluated the associations of mobile phone use with the risks of brain, acoustic neuroma, and parotid gland tumors. In the main publication of the multinational Interphone Study, investigators concluded that biases and errors prevented a causal interpretation. We applied a probabilistic multiple-bias model to address possible biases simultaneously, using validation data from billing records and nonparticipant questionnaires as information on recall error and selective participation. In our modeling, we sought to adjust for these sources of uncertainty and to facilitate interpretation. For glioma, when comparing those in the highest quartile of use (>558 lifetime hours) to those who were not regular users, the odds ratio was 2.0 (95% confidence interval: 1.2, 3.4). After adjustment for selection and recall biases, the odds ratio was 2.2 (95% limits: 1.3, 4.1). There was little evidence of an increase in the risk of meningioma, acoustic neuroma, or parotid gland tumors in relation to mobile phone use. Adjustments for selection and recall biases did not materially affect interpretation in our results from Canadian data.

Authors

  • Momoli, F, Momoli F,

  • Siemiatycki, J, Siemiatycki J,

  • McBride, M L, McBride ML,

  • Parent, M-E, Parent ME,

  • Richardson, L, Richardson L,

  • Bedard, D, Bedard D,

  • Platt, R, Platt R,

  • Vrijheid, M, Vrijheid M,

  • Cardis, E, Cardis E,

  • Krewski, D, Krewski D,

YEAR OF PUBLICATION: 2017
SOURCE: Am J Epidemiol. 2017 Oct 1;186(7):885-893. doi: 10.1093/aje/kwx157.
JOURNAL TITLE ABBREVIATION: Am J Epidemiol
JOURNAL TITLE: American journal of epidemiology
ISSN: 1476-6256 (Electronic) 0002-9262 (Print) 0002-9262 (Linking)
VOLUME: 186
ISSUE: 7
PAGES: 885-893
PLACE OF PUBLICATION: United States
ABSTRACT:
We undertook a re-analysis of the Canadian data from the 13-country case-control Interphone Study (2001-2004), in which researchers evaluated the associations of mobile phone use with the risks of brain, acoustic neuroma, and parotid gland tumors. In the main publication of the multinational Interphone Study, investigators concluded that biases and errors prevented a causal interpretation. We applied a probabilistic multiple-bias model to address possible biases simultaneously, using validation data from billing records and nonparticipant questionnaires as information on recall error and selective participation. In our modeling, we sought to adjust for these sources of uncertainty and to facilitate interpretation. For glioma, when comparing those in the highest quartile of use (>558 lifetime hours) to those who were not regular users, the odds ratio was 2.0 (95% confidence interval: 1.2, 3.4). After adjustment for selection and recall biases, the odds ratio was 2.2 (95% limits: 1.3, 4.1). There was little evidence of an increase in the risk of meningioma, acoustic neuroma, or parotid gland tumors in relation to mobile phone use. Adjustments for selection and recall biases did not materially affect interpretation in our results from Canadian data.
COPYRIGHT INFORMATION: (c) The Author(s) 2017. Published by Oxford University Press on behalf of the Johns||Hopkins Bloomberg School of Public Health. All rights reserved. For permissions,||please e-mail: journals.permissions@oup.com.
LANGUAGE: eng
DATE OF PUBLICATION: 2017 Oct 1
DATE COMPLETED: 20171023
DATE REVISED: 20211130
MESH DATE: 2017/10/24 06:00
EDAT: 2017/05/24 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1093/aje/kwx157 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli